Published-Ahead-of-Print July 12, 2006, DOI:10.2164/jandrol.106.000349
Journal of Andrology, Vol. 27, No. 6, November/December 2006
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.106.000349
Transgenerational Effect of the Endocrine Disruptor Vinclozolin on Male Spermatogenesis
MATTHEW D. ANWAY,
MUSHTAQ A. MEMON,
MEHMET UZUMCU* AND
MICHAEL K. SKINNER
From the Center for Reproductive Biology, School of Molecular
Biosciences, Washington State University, Pullman, Washington.
|
Correspondence to: Michael K. Skinner, Center for Reproductive Biology, School
of Molecular Biosciences, Washington State University, Pullman, WA 99164-4231
(e-mail:
skinner{at}mail.wsu.edu). |
The current study was designed to examine the actions of a model endocrine
disruptor on embryonic testis development and male fertility. Pregnant rats
(F0) that received a transient embryonic exposure to an environmental
endocrine disruptor, vinclozolin, had male offspring (F1) with reduced
spermatogenic capacity. The reduced spermatogenetic capacity observed in the
F1 male offspring was transmitted to the subsequent generations (F2F4).
The administration of vinclozolin, an androgen receptor antagonist, at 100
mg/kg/day from embryonic day 814 (E8E14) of pregnancy to only
the F0 dam resulted in a transgenerational phenotype in the subsequent male
offspring in the F1F4 generations. The litter size and male/female sex
ratios were similar in controls and the vinclozolin generations. The average
testes/body weight index of the postnatal day 60 (P60) males was not
significantly different in the vinclozolin-treated generations compared to the
controls. However, the testicular spermatid number, as well as the epididymal
sperm number and motility, were significantly reduced in the vinclozolin
generations compared to the control animals. Postnatal day 20 (P20) testis
from the vinclozolin F2 generation had no morphological abnormalities, but did
have an increase in spermatogenic cell apoptosis. Although the P60 testis
morphology was predominantly normal, the germ cell apoptosis was significantly
increased in the testes cross sections of animals from the vinclozolin
generations. The increase in apoptosis was stage-specific in the testis, with
tubules at stages IXXIV having the highest increase in apoptotic germ
cells. The tubules at stages IV also had an increase in apoptotic germ
cells compared to the control samples, but tubules at stages VIVIII had
no increase in apoptotic germ cells. An outcross of a vinclozolin generation
male with a wild-type female demonstrated that the reduced spermatogenic cell
phenotype was transmitted through the male germ line. An outcross with a
vinclozolin generation female with a wild-type male had no phenotype. A
similar phenotype was observed in outbred Sprague Dawley and inbred Fisher rat
strains. Observations demonstrate that a transient exposure at the time of
male sex determination to the antiandrogenic endocrine disruptor vinclozolin
can induce an apparent epigenetic transgenerational phenotype with reduced
spermatogenic capacity.
Key words: Epigenetic, testis, gametogenesis, male infertility, antiandrogen, apoptosis
This article has been cited by other articles:

|
 |

|
 |
 
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease
Reproduction,
May 1, 2008;
135(5):
713 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Vahter
Interactions between Arsenic-Induced Toxicity and Nutrition in Early Life
J. Nutr.,
December 1, 2007;
137(12):
2798 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. McClusky, C de Jager, and M. Bornman
Stage-Related Increase in the Proportion of Apoptotic Germ Cells and Altered Frequencies of Stages in the Spermatogenic Cycle Following Gestational, Lactational, and Direct Exposure of Male Rats to p-Nonylphenol
Toxicol. Sci.,
January 1, 2007;
95(1):
249 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by The American Society of Andrology.